Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response
Clinical trial NCT00483223 · COMPLETED
Trial details
- NCT number
- NCT00483223
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2014-06-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.